Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AbbVie is 'Hold'. Macroaxis provides AbbVie buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The advice algorithm takes into account all of AbbVie available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AbbVie buy-and-hold prospective. Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.
For the selected time horizon AbbVie has a risk adjusted performance of (0.07), jensen alpha of (0.39), total risk alpha of (0.89), sortino ratio of 0.0 and treynor ratio of (1.52)Macroaxis provides unbiased buy, hold, or sell recommendation on AbbVie that should be used to complement current analysts and expert consensus on AbbVie. Our buy or sell advice engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure AbbVie is not overpriced, please confirm all AbbVie fundamentals including its Shares Outstanding, Net Income, Price to Earnings To Growth, as well as the relationship between Price to Book and Current Ratio . Given that AbbVie has Price to Earning of 19.46X, we suggest you validate AbbVie market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
AbbVie exhibits very low volatility with skewness of -4.25 and kurtosis of 24.67. However, we advise investors to further study AbbVie technical indicators to make sure all market info is available and is reliable.